Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy

NCT05862233 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients

NCT05039190 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

NCT04830644 ·Status: UNKNOWN ·Phase: PHASE2

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

NCT01625182 ·Status: COMPLETED ·Phase: PHASE3

Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

NCT06859099 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Sacral Nerve Stimulation for Mild-to-Moderate or Refractory Rheumatoid Arthritis

NCT04821050 ·Status: UNKNOWN ·Phase: NA

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

NCT06046222 ·Status: RECRUITING ·Phase: PHASE2

Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis

NCT02039687 ·Status: COMPLETED ·Phase: PHASE2

A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders

NCT03330418 ·Status: TERMINATED ·Phase: PHASE3

The Phase I Study of Recombinant Human Nerve Growth Factor Injection

NCT04232332 ·Status: UNKNOWN ·Phase: PHASE1

Rituximab to Treat Neuropathy With Anti-MAG Antibodies

NCT00050245 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

NCT06952413 ·Status: RECRUITING ·Phase: PHASE2

A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

NCT04948554 ·Status: TERMINATED ·Phase: PHASE1

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome

NCT05856526 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04281472 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

NCT04280718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies

NCT03864185 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

NCT00930683 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Clinical Trial of Meplazumab in Healthy Volunteer

NCT04369586 ·Status: COMPLETED ·Phase: PHASE1

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

NCT02565576 ·Status: COMPLETED ·Phase: PHASE2

Study of CM310 in Healthy Subjects

NCT06161090 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis

NCT06284954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

NCT04163419 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

NCT05403138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

NCT01086540 ·Status: COMPLETED ·Phase: PHASE2